Existence of functional M3-muscarinic receptors in the human heart

被引:0
作者
Pia Willmy-Matthes
Kirsten Leineweber
Thekla Wangemann
Ralf-Edgar Silber
Otto-Erich Brodde
机构
[1] University of Halle,Institute of Pharmacology
[2] University of Essen School of Medicine,Departments of Pathophysiology and Nephrology
[3] University of Halle,Clinic of Cardiothoracic Surgery
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2003年 / 368卷
关键词
Human right atrium; Inositol phosphates; M; -receptors; Darifenacin; Carbachol;
D O I
暂无
中图分类号
学科分类号
摘要
It has been recently shown that, in adult rat ventricular cardiomyocytes, functional muscarinic receptors (M-receptors) of the M3-subtype exist that mediate inositol phosphate (IP) formation. The aim of this study was to characterize the M-receptor subtype mediating IP formation in the human heart. For this purpose in [3H]-myo-inositol labeled slices of human right atria, carbachol-induced [3H]-IP formation and its inhibition by several M-receptor antagonists was assessed. Carbachol (0.1 μM–100 μM) increased [3H]-IP formation; maximal increase at 100 μM was 93±16% above basal (n=20); the pEC50-value for carbachol was 5.56. Atropine (1 μM) completely suppressed 100 μM carbachol-induced [3H]-IP formation. Among the M-receptor subtype “selective” antagonists himbacine (1 μM) and pirenzepine (1 μM) only marginally affected carbachol-induced [3H]-IP formation whereas the M3-receptor antagonist darifenacin (1 nM–1 μM) concentration-dependently inhibited carbachol-induced [3H]-IP formation with a pKi-value of 8.49. We conclude that in human right atrium there exist functional M3-receptors that couple to IP formation.
引用
收藏
页码:316 / 319
页数:3
相关论文
共 26 条
[1]  
Bristow C(1988)Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors? J Pharmacol Exp Ther 247 1039-531
[2]  
Brodde C(1999)Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium Pharmacol Rev 51 651-352
[3]  
Brodde C(1995)undefined Cardiovasc Res 30 570-undefined
[4]  
Caulfield T(1998)undefined Pharmacol Rev 50 279-undefined
[5]  
Dhein S(2001)undefined Pharmacol Res 44 161-undefined
[6]  
Hellgren MC(2000)undefined Cell Mol Life Sci 57 175-undefined
[7]  
Kories H-R(2003)undefined Naunyn-Schmiedebergs Arch Pharmacol 367 524-undefined
[8]  
Czyborra A(2001)undefined Circulation 103 1638-undefined
[9]  
Fetscher K(2003)undefined Br J Pharmacol 138 156-undefined
[10]  
Schneider S(1997)undefined J Pharmacol Exp Ther 280 721-undefined